rs72554322
Positions:
Variant summary
Our verdict is Pathogenic. Variant got 12 ACMG points: 12P and 0B. PVS1PM2PP5_Moderate
The ENST00000039007.5(OTC):c.174G>A(p.Trp58Ter) variant causes a stop gained change. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★). Variant results in nonsense mediated mRNA decay.
Frequency
Genomes: not found (cov: 22)
Exomes 𝑓: 0.0 ( 0 hom. 0 hem. )
Failed GnomAD Quality Control
Consequence
OTC
ENST00000039007.5 stop_gained
ENST00000039007.5 stop_gained
Scores
2
2
1
Clinical Significance
Conservation
PhyloP100: 6.07
Genes affected
OTC (HGNC:8512): (ornithine transcarbamylase) This nuclear gene encodes a mitochondrial matrix enzyme. The encoded protein is involved in the urea cycle which functions to detoxify ammonia into urea for excretion. Mutations in this enzyme lead to ornithine transcarbamylase deficiency, which causes hyperammonemia. [provided by RefSeq, May 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Pathogenic. Variant got 12 ACMG points.
PVS1
Loss of function variant, product undergoes nonsense mediated mRNA decay. LoF is a known mechanism of disease.
PM2
Very rare variant in population databases, with high coverage;
PP5
Variant X-38367387-G-A is Pathogenic according to our data. Variant chrX-38367387-G-A is described in ClinVar as [Pathogenic]. Clinvar id is 97127.Status of the report is criteria_provided_single_submitter, 1 stars. Variant chrX-38367387-G-A is described in Lovd as [Likely_pathogenic].
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
OTC | NM_000531.6 | c.174G>A | p.Trp58Ter | stop_gained | 2/10 | ENST00000039007.5 | NP_000522.3 | |
OTC | NM_001407092.1 | c.174G>A | p.Trp58Ter | stop_gained | 4/12 | NP_001394021.1 | ||
OTC | XM_017029556.2 | c.174G>A | p.Trp58Ter | stop_gained | 2/9 | XP_016885045.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
OTC | ENST00000039007.5 | c.174G>A | p.Trp58Ter | stop_gained | 2/10 | 1 | NM_000531.6 | ENSP00000039007 | P1 | |
OTC | ENST00000488812.1 | n.266G>A | non_coding_transcript_exon_variant | 2/6 | 5 | |||||
OTC | ENST00000643344.1 | c.174G>A | p.Trp58Ter | stop_gained, NMD_transcript_variant | 2/11 | ENSP00000496606 |
Frequencies
GnomAD3 genomes Cov.: 22
GnomAD3 genomes
Cov.:
22
GnomAD4 exome Data not reliable, filtered out with message: AC0 AF: 0.00 AC: 0AN: 1089186Hom.: 0 Cov.: 28 AF XY: 0.00 AC XY: 0AN XY: 355098
GnomAD4 exome
Data not reliable, filtered out with message: AC0
AF:
AC:
0
AN:
1089186
Hom.:
Cov.:
28
AF XY:
AC XY:
0
AN XY:
355098
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome Cov.: 22
GnomAD4 genome
Cov.:
22
ClinVar
Significance: Pathogenic
Submissions summary: Pathogenic:2
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Ornithine carbamoyltransferase deficiency Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Laboratorio de Genetica e Diagnostico Molecular, Hospital Israelita Albert Einstein | May 30, 2022 | ACMG classification criteria: PVS1 very strong, PS4 supporting, PM2 moderated - |
not provided Pathogenic:1
Pathogenic, no assertion criteria provided | literature only | GenMed Metabolism Lab | - | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Pathogenic
D
BayesDel_noAF
Pathogenic
CADD
Pathogenic
DANN
Uncertain
FATHMM_MKL
Uncertain
D
MutationTaster
Benign
A
Vest4
GERP RS
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at